TECH

SELL

Bio-Techne Corp

Healthcare · Rank #221 · Analyzed Jul 13, 2026

$71.30

Current Price

$26.99

Intrinsic Value

-62.1%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 62.1%

Fair Value Range

Low$10.48

Base (IV)$26.99

High$36.36

Entry Points

Conservative$7.33

Moderate$10.48

Aggressive$18.89

Quality & Moat Breakdown

Return on Equity5.3% → 0/1.0

Debt LevelD/E 14 → 1.0/1.0

Revenue QualityGrowth 13.4%, margin Δ-23.5% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins9.0% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.